158 related articles for article (PubMed ID: 8165538)
1. Pharmacologic treatment of desmoid tumors in familial adenomatous polyposis: results of an in vitro study.
Tonelli F; Valanzano R; Brandi ML
Surgery; 1994 Apr; 115(4):473-9. PubMed ID: 8165538
[TBL] [Abstract][Full Text] [Related]
2. [Desmoid tumors in patients with familial adenomatous polyposis (FAP). Clinical and therapeutic observations from the Heidelberg polyposis register].
Kadmon M; Möslein G; Buhr HJ; Herfarth C
Chirurg; 1995 Oct; 66(10):997-1005. PubMed ID: 8529453
[TBL] [Abstract][Full Text] [Related]
3. In vitro bioeffects of the antiestrogen LY117018 on desmoid tumor and colon cancer cells.
Picariello L; Fiorelli G; Benvenuti S; Brandi ML; Galli G; Malentacchi C; Montali E; Bigozzi U; Ficari F; Tonelli F
Anticancer Res; 1997; 17(3C):2099-104. PubMed ID: 9216671
[TBL] [Abstract][Full Text] [Related]
4. Ureteric obstruction in familial adenomatous polyposis-associated desmoid disease.
Joyce M; Mignanelli E; Church J
Dis Colon Rectum; 2010 Mar; 53(3):327-32. PubMed ID: 20173481
[TBL] [Abstract][Full Text] [Related]
5. Identification and progression of a desmoid precursor lesion in patients with familial adenomatous polyposis.
Clark SK; Smith TG; Katz DE; Reznek RH; Phillips RK
Br J Surg; 1998 Jul; 85(7):970-3. PubMed ID: 9692575
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive genetic and endoscopic evaluation may be necessary to distinguish sporadic versus familial adenomatous polyposis-associated abdominal desmoid tumors.
Bandipalliam P; Balmana J; Syngal S
Surgery; 2004 Jun; 135(6):683-9. PubMed ID: 15179376
[TBL] [Abstract][Full Text] [Related]
7. Intracranial desmoid tumor with familial adenomatous polyposis coli.
Yazici N; Yalçin B; Soylemezoğlu F; Cila A; Akalan N; Koksal Y; Buyukpamukçu M
Pediatr Neurosurg; 2008; 44(2):140-3. PubMed ID: 18230929
[TBL] [Abstract][Full Text] [Related]
8. Gardner fibroma: a clinicopathologic and immunohistochemical analysis of 45 patients with 57 fibromas.
Coffin CM; Hornick JL; Zhou H; Fletcher CD
Am J Surg Pathol; 2007 Mar; 31(3):410-6. PubMed ID: 17325483
[TBL] [Abstract][Full Text] [Related]
9. Staging intra-abdominal desmoid tumors in familial adenomatous polyposis: a search for a uniform approach to a troubling disease.
Church J; Berk T; Boman BM; Guillem J; Lynch C; Lynch P; Rodriguez-Bigas M; Rusin L; Weber T;
Dis Colon Rectum; 2005 Aug; 48(8):1528-34. PubMed ID: 15906134
[TBL] [Abstract][Full Text] [Related]
10. [Current diagnosis and treatment of desmoid tumours in patients with familial adenomatous polyposis - the surgical view].
Jannasch O; Evert M; Rapp L; Lippert H; Meyer F
Zentralbl Chir; 2010 Feb; 135(1):34-43. PubMed ID: 19908178
[TBL] [Abstract][Full Text] [Related]
11. Combination chemotherapy for desmoid tumors.
Okuno SH; Edmonson JH
Cancer; 2003 Feb; 97(4):1134-5. PubMed ID: 12569616
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome of sporadic and FAP-associated desmoid tumors treated with high-dose selective estrogen receptor modulators and sulindac: a single-center long-term observational study in 134 patients.
Quast DR; Schneider R; Burdzik E; Hoppe S; Möslein G
Fam Cancer; 2016 Jan; 15(1):31-40. PubMed ID: 26275868
[TBL] [Abstract][Full Text] [Related]
13. Ki-67 expression and residual tumour (R) classification are associated with disease-free survival in desmoid tumour patients.
Brueckl WM; Preuss JM; Wein A; Jung A; Brabletz T; Pflüger R; Wiest GH; Wolfl C; Kirchner T; Hahn EG; Hohenberger W; Günther K
Anticancer Res; 2001; 21(5):3615-20. PubMed ID: 11848532
[TBL] [Abstract][Full Text] [Related]
14. Dacarbazine-Doxorubicin therapy ameliorated an extremely aggressive mesenteric desmoid tumor associated with familial adenomatous polyposis: report of a case.
Ezumi K; Yamamoto H; Takemasa I; Nomura M; Ikeda M; Sekimoto M; Monden M
Jpn J Clin Oncol; 2008 Mar; 38(3):222-6. PubMed ID: 18304951
[TBL] [Abstract][Full Text] [Related]
15. [Desmoid tumor in familial adenomatous polyposis].
Knudsen AL; Bülow S
Ugeskr Laeger; 2000 Oct; 162(42):5628-31. PubMed ID: 11059301
[TBL] [Abstract][Full Text] [Related]
16. Toremifene decreases type I, type II and increases type III receptors in desmoid and fibroma and inhibits TGFbeta1 binding in desmoid fibroblasts.
Stabellini G; Balducci C; Lilli C; Marinucci L; Becchetti E; Carinci F; Calastrini C; Dolci C; Lumare E; Locci P
Biomed Pharmacother; 2008 Sep; 62(7):436-42. PubMed ID: 18155395
[TBL] [Abstract][Full Text] [Related]
17. Genetic deletion of receptor for hyaluronan-mediated motility (Rhamm) attenuates the formation of aggressive fibromatosis (desmoid tumor).
Tolg C; Poon R; Fodde R; Turley EA; Alman BA
Oncogene; 2003 Oct; 22(44):6873-82. PubMed ID: 14534534
[TBL] [Abstract][Full Text] [Related]
18. Significance of incidental desmoids identified during surgery for familial adenomatous polyposis.
Hartley JE; Church JM; Gupta S; McGannon E; Fazio VW
Dis Colon Rectum; 2004 Mar; 47(3):334-8; discussion 339-40. PubMed ID: 14991495
[TBL] [Abstract][Full Text] [Related]
19. Desmoid tumors in a dutch cohort of patients with familial adenomatous polyposis.
Nieuwenhuis MH; De Vos Tot Nederveen Cappel W; Botma A; Nagengast FM; Kleibeuker JH; Mathus-Vliegen EM; Dekker E; Dees J; Wijnen J; Vasen HF
Clin Gastroenterol Hepatol; 2008 Feb; 6(2):215-9. PubMed ID: 18237870
[TBL] [Abstract][Full Text] [Related]
20. Response of extraabdominal desmoid tumors to therapy with imatinib mesylate.
Mace J; Sybil Biermann J; Sondak V; McGinn C; Hayes C; Thomas D; Baker L
Cancer; 2002 Dec; 95(11):2373-9. PubMed ID: 12436445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
